AVENUE THERAPEUTICS, INC. Operating Income

Quick Answer

AVENUE THERAPEUTICS, INC. reported Operating Income of -$3.08 million for fiscal year 2025.

AVENUE THERAPEUTICS, INC. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$3.08M +72.7%
2024 -$11.28M +22.4%
2023 -$14.54M -80.8%
2022 -$8.04M -115.2%
2021 -$3.74M +28.3%
2020 -$5.21M +80.2%
2019 -$26.27M -20.4%
2018 -$21.82M -91.0%
2017 -$11.42M -380.5%
2016 -$2.38M +50.9%
2015 -$4.84M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$724.0K +77.1% -343.8%
June 30, 2025 $297.0K +110.5% +115.6%
March 31, 2025 -$1.91M +48.6% +39.6%
September 30, 2024 -$3.16M -52.6% -11.8%
June 30, 2024 -$2.82M +28.0% +23.9%
March 31, 2024 -$3.71M +42.3% -79.3%
September 30, 2023 -$2.07M -211.9% +47.3%
June 30, 2023 -$3.92M -548.4% +39.0%
  • AVENUE THERAPEUTICS, INC. showed an increase of +72.7% in Operating Income compared to the prior fiscal year.
  • Over the 2015–2025 period, AVENUE THERAPEUTICS, INC.’s operating income has grown by 36.3% (from -$4.84 million to -$3.08 million).
  • The most recent figure is from AVENUE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment